Z Dong Selected Research

Z Dong Research Topics

Disease

50	Neoplasms (Cancer) 01/2020 - 01/2000
13	Carcinogenesis 01/2016 - 01/2000
9	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2000
8	Nasal Polyps (Nasal Polyp) 10/2001 - 08/2000
7	Breast Neoplasms (Breast Cancer) 10/2015 - 08/2001
6	Prostatic Neoplasms (Prostate Cancer) 05/2023 - 03/2001
5	Body Weight (Weight, Body) 01/2023 - 07/2015
5	Infections 01/2019 - 06/2000
5	Inflammation (Inflammations) 01/2013 - 03/2001
4	Obesity 01/2024 - 07/2015
4	Adenocarcinoma 08/2012 - 02/2000
4	Necrosis 07/2007 - 03/2000
4	Hypoxia (Hypoxemia) 11/2001 - 05/2000
3	Periodontitis 01/2024 - 02/2010
3	Hypertension (High Blood Pressure) 09/2023 - 02/2022
3	Dyslipidemias (Dyslipidemia) 06/2023 - 08/2020
3	Snoring 08/2020 - 08/2000
3	Carcinoma (Carcinomatosis) 02/2017 - 03/2001
3	Skin Neoplasms (Skin Cancer) 03/2016 - 11/2000
3	Stomach Neoplasms (Stomach Cancer) 04/2014 - 09/2000
3	Colonic Neoplasms (Colon Cancer) 01/2014 - 01/2000
3	Ovarian Neoplasms (Ovarian Cancer) 08/2013 - 02/2008
2	Insulin Resistance 01/2024 - 06/2012
2	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 10/2008
2	Chronic Disease (Chronic Diseases) 03/2022 - 08/2020
2	Overweight 08/2020 - 06/2012
2	Squamous Cell Carcinoma of Head and Neck 01/2019 - 10/2008
2	Ischemic Stroke 01/2018 - 05/2015
2	Hypersensitivity (Allergy) 01/2018 - 05/2001
2	Colorectal Neoplasms (Colorectal Cancer) 10/2017 - 01/2000
2	Headache (Headaches) 02/2017 - 09/2013
2	Nasopharyngeal Carcinoma 09/2014 - 12/2011
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2009 - 01/2000
2	Hepatitis 04/2006 - 06/2000
2	Rhinitis 05/2001 - 02/2000
2	Obstructive Sleep Apnea 03/2001 - 10/2000

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 09/2023 - 01/2000
10	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 11/2004 - 01/2000
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2015 - 02/2000
6	TeaIBA 12/2001 - 01/2000
5	DNA (Deoxyribonucleic Acid)IBA 02/2016 - 03/2001
4	Messenger RNA (mRNA)IBA 01/2015 - 08/2001
4	CarcinogensIBA 01/2013 - 01/2000
4	Phosphotransferases (Kinase)IBA 04/2012 - 01/2000
4	Cisplatin (Platino)FDA LinkGeneric 12/2011 - 07/2006
4	NF-kappa B (NF-kB)IBA 02/2008 - 10/2000
4	ParaffinIBA 08/2001 - 04/2000
3	LigandsIBA 01/2024 - 02/2009
3	LeptinIBA 01/2023 - 04/2014
3	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 06/2012
3	LipidsIBA 02/2022 - 06/2001
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018 - 01/2015
3	Therapeutic UsesIBA 01/2014 - 01/2000
3	Protein Isoforms (Isoforms)IBA 02/2009 - 08/2001
3	CaspasesIBA 10/2008 - 05/2000
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2008 - 02/2000
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2006 - 01/2000
3	Mitogen-Activated Protein KinasesIBA 12/2001 - 01/2000
3	PolyphenolsIBA 12/2001 - 01/2000
3	arseniteIBA 09/2001 - 01/2000
2	oxidized low density lipoproteinIBA 06/2023 - 08/2020
2	Pharmaceutical Sleep AidsIBA 08/2020 - 08/2020
2	MicroRNAs (MicroRNA)IBA 01/2020 - 08/2013
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 02/2016 - 07/2015
2	Fibronectins (Fibronectin)IBA 10/2015 - 03/2011
2	IntegrinsIBA 10/2015 - 03/2011
2	CateninsIBA 08/2014 - 01/2011
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2014 - 01/2013
2	LuciferasesIBA 11/2013 - 05/2006
2	Adenosine Triphosphate (ATP)IBA 09/2013 - 06/2001
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 08/2013 - 02/2008
2	CytokinesIBA 06/2011 - 04/2006
2	Transforming Growth Factor beta (TGF-beta)IBA 06/2011 - 02/2009
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 02/2009 - 07/2001
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2008 - 08/2001
2	Caspase 9IBA 10/2008 - 11/2001
2	Protein Kinase CIBA 02/2008 - 12/2001
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2007 - 05/2001
2	Interferon-betaIBA 07/2006 - 07/2001
2	Matrix Metalloproteinases (MMPs)IBA 12/2001 - 08/2001
2	Transcription Factors (Transcription Factor)IBA 07/2001 - 06/2001
2	Epidermal Growth Factor (EGF)IBA 06/2001 - 01/2000
2	CollagenIBA 03/2001 - 10/2000
2	Monoclonal AntibodiesIBA 03/2001 - 09/2000
2	ResveratrolIBA 02/2001 - 11/2000
2	Interleukin-1beta (Interleukin 1 beta)IBA 10/2000 - 08/2000
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 10/2000 - 01/2000
2	JBT-3002IBA 06/2000 - 01/2000
1	6-formylindolo(3,2-b)carbazoleIBA 01/2024
1	tryptamineIBA 01/2024
1	indoleacetic acid (indole acetic acid)IBA 01/2024
1	indole-3-carbaldehydeIBA 01/2024
1	indoleIBA 01/2024

Therapy/Procedure

11	Therapeutics 05/2022 - 01/2000
6	Chemoprevention 10/2017 - 07/2000
3	Drug Therapy (Chemotherapy) 01/2014 - 09/2000
2	Oral Administration 01/2024 - 12/2008
2	Ligation 01/2024 - 01/2017
2	Thyroidectomy 02/2017 - 01/2017
2	Radiotherapy 02/2017 - 09/2014